Comprehensive analysis of the role of a four-gene signature based on EMT in the prognosis, immunity, and treatment of lung squamous cell carcinoma
Figure 7. (A) The sensitivity of the high- and low-risk groups to six commonly used chemotherapeutic drugs. (B) The sensitivity of the high- and low-risk groups to targeted drugs with significant differences.